{
    "id": "0614",
    "question": "A 75-year-old man presents to the emergency department with a racing heart and lightheadedness for 3 hours. He has had similar episodes in the past, but the symptoms never lasted this long. He denies chest pain, shortness of breath, headaches, and fevers. He had a myocardial infarction 4 years ago and currently takes captopril, metoprolol, and atorvastatin. His pulse is irregular and cardiac auscultation reveals an irregular heart rhythm. Laboratory reports show:\nSerum glucose 88 mg/dL\nSodium 142 mEq/L\nPotassium 3.9 mEq/L\nChloride 101 mEq/L\nSerum creatinine 0.8 mg/dL\nBlood urea nitrogen 10 mg/dL\nCholesterol, total 170 mg/dL\nHDL-cholesterol 40 mg/dL\nLDL-cholesterol 80 mg/dL\nTriglycerides 170 mg/dL\nHematocrit 38%\nHemoglobin 13 g/dL\nLeucocyte count 7,500/mm3\nPlatelet count 185,000 /mm3\nActivated partial thromboplastin time (aPTT) 30 seconds\nProthrombin time (PT) 12 seconds\nCardiac enzymes Negative\nAn ECG shows the absence of P-waves with an irregular RR complex. A few hours later, his symptoms subside and he is discharged with an additional anticoagulation drug. Which of the following mechanisms explains how this new medication will exert its effects?",
    "options": {
        "A": "Activation of the antithrombin enzyme",
        "B": "Inhibition of the cyclooxygenase enzyme",
        "C": "Inhibition of vitamin K-dependent clotting factors",
        "D": "Blockage of glycoprotein IIb/IIIa receptors"
    },
    "answer": "C",
    "predict": "Here's the step-by-step thinking to determine the correct answer: 1. **Clinical Presentation**: The patient presents with symptoms of a racing heart and lightheadedness, which have persisted for 3 hours. He has a history of myocardial infarction and takes medications for hypertension and hyperlipidemia. The irregular heart rhythm, as evidenced by the ECG, suggests a possible arrhythmia. 2. **Laboratory Results**: The patient's laboratory results show a slightly elevated hematocrit and hemoglobin, which could be indicative of polycythemia (an increased red blood cell mass). The absence of P-waves on the ECG and an irregular RR complex suggest atrial fibrillation (AF), a common cardiac arrhythmia. 3. **Previous Medications**: The patient is taking captopril (an ACE inhibitor), metoprolol (a beta-blocker), and atorvastatin (a statin). These medications are used to manage hypertension, heart failure, and hyperlipidemia, respectively. 4. **New Medication**: Given the patient's history of atrial fibrillation and the symptoms persisting for an extended period, the new medication is likely intended to prevent thromboembolic events, such as stroke. 5. **Mechanism of Action**: Now, let's analyze the options: - A. **Activation of the antithrombin enzyme**: Antithrombin is a naturally occurring inhibitor of thrombin, but it is not typically used as a medication. - B. **Inhibition of the cyclooxygenase enzyme**: This refers to nonsteroidal anti-inflammatory drugs (NSAIDs), which are not typically used for anticoagulation. - C. **Inhibition of vitamin K-dependent clotting factors**: This refers to warfarin, a commonly used anticoagulant that inhibits vitamin K-dependent clotting factors (II, VII, IX, and X). - D. **Blockage of glycoprotein IIb/IIIa receptors**: This refers to glycoprotein IIb/IIIa inhibitors, such as abciximab, which are used during coronary interventions to prevent platelet aggregation. **Conclusion**: Given the patient's history of atrial fibrillation and the need for anticoagulation, the most likely medication is warfarin, which inhibits vitamin K-dependent clotting factors. Here's the answer in JSON format: ```json { \"step_by_step_thinking\": \"The patient's symptoms and history suggest atrial fibrillation, a common cardiac arrhythmia. The new medication is intended to prevent thromboembolic events, such as stroke. The most likely medication is warfarin, which inhibits vitamin K-dependent clotting factors.\", \"answer_choice\": \"C\" } ```",
    "snippets": [],
    "scores": [],
    "execution_time": 62.67369627952576
}